☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
GC Biopharma
GC Biopharma Receives the US FDA Approval for Alyglo (GC5107B),10% Liquid for the treatment of Primary Humoral Immunodeficiency (P...
December 18, 2023
GC Biopharma's GC1126A Receives the US FDA’s Orphan Drug Designation for Thrombotic Thrombocytopenic Purpura
October 6, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.